Differentiated thyroid carcinoma : treatment and clinical consequences of therapy

The first chapters of this thesis describe the treatment of radioiodine non-avid thyroid carcinoma with the tyrosine kinase inhibitor sorafenib. The remainder of the thesis describes the clinical consequences of the treatment of thyroid carcinoma.Bayer B.V. Novo Nordisk B.V. Servier Nederland Farma B.V. MSD B.V. Genzyme B.V. AstraZeneca B.V. Ipsen Farmaceutica B.V. Novartis Pharma B.V. J.E. Jurriaanse StichtingUBL - phd migration 201